Investigation of the Efficacy and Safety of CHI-921 in Insomnia.

PHASE2TerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 21, 2019

Primary Completion Date

June 17, 2020

Study Completion Date

June 17, 2020

Conditions
Insomnia
Interventions
DRUG

CHI-921

a standardized cannabis extract in sunflower oil administered in oral liquid (oil) form

DRUG

Placebo

Placebo is a vehicle oil will match CHI-921

Trial Locations (1)

H3B 1P5

Algorithme Pharma Inc., Montreal

Sponsors
All Listed Sponsors
collaborator

Galenova Inc

OTHER

collaborator

Algorithme Pharma Inc

INDUSTRY

collaborator

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

OTHER

collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

lead

Canopy Growth Corporation

INDUSTRY

NCT03984604 - Investigation of the Efficacy and Safety of CHI-921 in Insomnia. | Biotech Hunter | Biotech Hunter